Morningstar's 2020 Genesystems Inc Stock Analysis
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
2020 Genesystems Inc's Company Profile
2020 Genesystems Inc is focused on reducing cancer deaths through the development and use of cancer biomarker test development. It pioneers bio-testing and cancer diagnostic tools that address compelling unmet needs. Its digital diagnostics business develops and commercializes A.I. powered cancer screenings tests deliver better tools to improve early detection of the most common cancers globally.